Back to search
FDAFDA · Food and drugs·Recall number D-0010-2023

Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7

Published October 26, 2022 · Recall initiated: September 30, 2022

Summary

FDA records drug Class II recall D-0010-2023, published October 26, 2022 and initiated September 30, 2022. Recalling firm: Ingenus Pharmaceuticals Llc; Status: Completed; Reported quantity: 6176 bottles; Lot: Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification for related substances (impurities).

What to do

Voluntary: Firm initiated · Letter

Get an email if FLUNISOLIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FLUNISOLIDE
Manufacturer
Ingenus Pharmaceuticals Llc
Distributor
Nationwide within the United States
UPC
350742317257
Lot
Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7 recalled?

Yes. FDA published recall D-0010-2023 on October 26, 2022. Reported hazard: Out of specification for related substances (impurities).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FLUNISOLIDE. UPC: 350742317257.